Search Results

Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19.

• Authors : Özcan, Özhan (AUTHOR); Çankayalı, İlkin (AUTHOR); Turhan, Ajda (AUTHOR)

• Source: Turkish Journal of Intensive Care. Dec2024, Vol. 22 Issue 4, p270-11. 11p.

Record details

Extensive characterization of COVID-19 convalescent plasma from Bulgarian donors.

• Authors : Donev, Vancho^1,2 (AUTHOR) ; Todorova, Yana¹ (AUTHOR); Emilova, Radoslava¹ (AUTHOR)

• Source: Biotechnology & Biotechnological Equipment. Dec2024, Vol. 38 Issue 1, p1-10. 10p.

Record details

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.

• Authors : Misset, Benoît^1,2 ; Diep, Anh Nguyet³; Bertrand, Axelle¹

• Source: Annals of Intensive Care. 10/21/2024, Vol. 14 Issue 1, p1-11. 11p.

Record details

Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic.

• Authors : Franchini, Massimo¹ (AUTHOR) ; Casadevall, Arturo² (AUTHOR) ; Dragotakes, Quigly² (AUTHOR)

• Source: Life (2075-1729). Sep2024, Vol. 14 Issue 9, p1207. 8p.

Record details

Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients.

• Authors : Franchini, Massimo¹ (AUTHOR) ; Mengoli, Carlo¹ (AUTHOR); Casadevall, Arturo² (AUTHOR)

• Source: Life (2075-1729). Jul2024, Vol. 14 Issue 7, p792. 14p.

Record details

Retrospective Analysis of Coronavirus SARS‐CoV‐2 Antibody Levels in COVID‐19 Convalescent Plasma From Blood Donors.

• Authors : He, Ji¹ (AUTHOR); Zhang, Yanjun² (AUTHOR); Dong, Jie¹ (AUTHOR)

• Source: Canadian Journal of Infectious Diseases & Medical Microbiology. 12/5/2024, Vol. 2024, p1-7. 7p.

Record details

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.

• Authors : Iasella, Carlo J.¹ (AUTHOR); Hannan, Stefanie J.² (AUTHOR); Lyons, Emily J.² (AUTHOR)

Subjects: *EMERGENCY use authorization; *CONVALESCENT plasma; *ANTIBODY titer

• Source: PLoS ONE. 10/24/2024, Vol. 19 Issue 10, p1-11. 11p.

Record details

Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation.

• Authors : Park, Hyung¹ (AUTHOR); Yu, Chang¹ (AUTHOR); Pirofski, Liise-anne² (AUTHOR)

• Source: BMC Infectious Diseases. 6/26/2024, Vol. 24 Issue 1, p1-11. 11p.

Record details

COVID-19 Convalescent Plasma Therapy: Long-term Implications.

• Authors : Yoon, Hyunah¹ (AUTHOR); Li, Yi² (AUTHOR); Goldfeld, Keith S² (AUTHOR)

• Source: Open Forum Infectious Diseases. Jan2024, Vol. 11 Issue 1, p1-9. 9p.

Record details

Factors related to the development of high antibody titres against SARS‐CoV‐2 in convalescent plasma donors from the ConPlas‐19 trial.

• Authors : Romera Martínez, Irene¹ (AUTHOR); Avendaño‐Solá, Cristina² (AUTHOR); Villegas Da Ros, Carolina³ (AUTHOR)

• Source: Vox Sanguinis. Jan2024, Vol. 119 Issue 1, p27-33. 7p.

Record details